Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.49 Billion USD | 12.59% |
| 2022 | 8.85 Billion USD | 9.91% |
| 2021 | 11.32 Billion USD | 11.13% |
| 2020 | 4.13 Billion USD | 38.25% |
| 2019 | 7.55 Billion USD | -30.66% |
| 2018 | 10.3 Billion USD | -39.4% |
| 2017 | 15.93 Billion USD | -18.9% |
| 2016 | 19.21 Billion USD | -19.18% |
| 2015 | 23.44 Billion USD | 46.36% |
| 2014 | 16.31 Billion USD | 238.15% |
| 2013 | 4.85 Billion USD | 13.65% |
| 2012 | 4.25 Billion USD | 3.02% |
| 2011 | 4.15 Billion USD | -4.13% |
| 2010 | 4.28 Billion USD | 12.62% |
| 2009 | 3.78 Billion USD | 30.04% |
| 2008 | 2.84 Billion USD | 23.95% |
| 2007 | 2.21 Billion USD | -45.65% |
| 2006 | -576.82 Million USD | 255.45% |
| 2005 | 1.14 Billion USD | 78.38% |
| 2004 | 688.17 Million USD | -24.32% |
| 2003 | 350.78 Million USD | 662.09% |
| 2002 | 81 Million USD | 140.91% |
| 2001 | -105.99 Million USD | -627.66% |
| 2000 | -40.31 Million USD | -144.78% |
| 1999 | -39.1 Million USD | 82.98% |
| 1998 | -65.1 Million USD | -46.9% |
| 1997 | -56.9 Million USD | -31.33% |
| 1996 | -31.6 Million USD | -37.06% |
| 1995 | -28.8 Million USD | -10.03% |
| 1994 | -31.3 Million USD | 0.0% |
| 1992 | -16.5 Million USD | -188.89% |
| 1991 | -5.3 Million USD | -32.5% |
| 1990 | -4 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.99 Billion USD | -236.56% |
| 2024 Q2 | 3.38 Billion USD | 184.24% |
| 2023 Q4 | 3.13 Billion USD | 18.86% |
| 2023 Q1 | 2.01 Billion USD | -16.76% |
| 2023 FY | - USD | 12.59% |
| 2023 Q2 | 2.05 Billion USD | 2.14% |
| 2023 Q3 | 2.64 Billion USD | 28.58% |
| 2022 Q3 | 3.1 Billion USD | 19.58% |
| 2022 Q2 | 2.6 Billion USD | 2923.26% |
| 2022 FY | - USD | 9.91% |
| 2022 Q4 | 2.41 Billion USD | -22.29% |
| 2022 Q1 | 86 Million USD | -91.37% |
| 2021 FY | - USD | 11.13% |
| 2021 Q1 | 2.58 Billion USD | 20.42% |
| 2021 Q2 | 2.16 Billion USD | -16.03% |
| 2021 Q3 | 3.7 Billion USD | 70.91% |
| 2021 Q4 | 997 Million USD | -73.1% |
| 2020 Q1 | 2.24 Billion USD | 4.66% |
| 2020 Q2 | 1.79 Billion USD | -20.19% |
| 2020 Q4 | 2.14 Billion USD | -3.9% |
| 2020 FY | - USD | 38.25% |
| 2020 Q3 | 2.23 Billion USD | 24.62% |
| 2019 Q4 | 2.14 Billion USD | 271.38% |
| 2019 Q1 | 2.6 Billion USD | 104.56% |
| 2019 FY | - USD | -30.66% |
| 2019 Q3 | -1.25 Billion USD | -147.07% |
| 2019 Q2 | 2.65 Billion USD | 2.07% |
| 2018 Q4 | 1.27 Billion USD | -56.52% |
| 2018 FY | - USD | -39.4% |
| 2018 Q3 | 2.92 Billion USD | 24.49% |
| 2018 Q2 | 2.35 Billion USD | 1.25% |
| 2018 Q1 | 2.32 Billion USD | -4.13% |
| 2017 Q4 | 2.42 Billion USD | -38.84% |
| 2017 Q1 | 3.87 Billion USD | -7.34% |
| 2017 FY | - USD | -18.9% |
| 2017 Q2 | 4.38 Billion USD | 13.05% |
| 2017 Q3 | 3.96 Billion USD | -9.63% |
| 2016 Q2 | 4.62 Billion USD | -2.24% |
| 2016 FY | - USD | -19.18% |
| 2016 Q1 | 4.73 Billion USD | -16.5% |
| 2016 Q3 | 4.51 Billion USD | -2.33% |
| 2016 Q4 | 4.18 Billion USD | -7.37% |
| 2015 Q4 | 5.66 Billion USD | 0.53% |
| 2015 Q3 | 5.63 Billion USD | -0.25% |
| 2015 Q2 | 5.65 Billion USD | 4.8% |
| 2015 Q1 | 5.39 Billion USD | 23.67% |
| 2015 FY | - USD | 46.36% |
| 2014 FY | - USD | 238.15% |
| 2014 Q4 | 4.36 Billion USD | 25.5% |
| 2014 Q3 | 3.47 Billion USD | -21.2% |
| 2014 Q1 | 3.02 Billion USD | 155.05% |
| 2014 Q2 | 4.4 Billion USD | 45.77% |
| 2013 Q3 | 1.15 Billion USD | 0.0% |
| 2013 FY | - USD | 13.65% |
| 2013 Q1 | 1.02 Billion USD | -7.8% |
| 2013 Q2 | 1.15 Billion USD | 12.88% |
| 2013 Q4 | 1.18 Billion USD | 2.8% |
| 2012 FY | - USD | 3.02% |
| 2012 Q4 | 1.1 Billion USD | 6.17% |
| 2012 Q3 | 1.04 Billion USD | -1.43% |
| 2012 Q2 | 1.05 Billion USD | 32.36% |
| 2012 Q1 | 800.18 Million USD | -17.27% |
| 2011 FY | - USD | -4.13% |
| 2011 Q4 | 967.26 Million USD | -4.99% |
| 2011 Q3 | 1.01 Billion USD | -1.03% |
| 2011 Q2 | 1.02 Billion USD | 12.33% |
| 2011 Q1 | 915.8 Million USD | -0.2% |
| 2010 Q2 | 1.01 Billion USD | -14.1% |
| 2010 Q3 | 994.66 Million USD | -1.61% |
| 2010 FY | - USD | 12.62% |
| 2010 Q4 | 917.66 Million USD | -7.74% |
| 2010 Q1 | 1.17 Billion USD | 3.15% |
| 2009 FY | - USD | 30.04% |
| 2009 Q2 | 773.98 Million USD | -9.12% |
| 2009 Q3 | 908.42 Million USD | 17.37% |
| 2009 Q4 | 1.14 Billion USD | 25.59% |
| 2009 Q1 | 851.62 Million USD | 7.11% |
| 2008 Q4 | 795.09 Million USD | 9.14% |
| 2008 Q3 | 728.5 Million USD | 11.83% |
| 2008 Q2 | 651.44 Million USD | -4.87% |
| 2008 Q1 | 684.78 Million USD | 30.7% |
| 2008 FY | - USD | 23.95% |
| 2007 Q3 | 562.56 Million USD | 0.92% |
| 2007 Q4 | 523.95 Million USD | -6.86% |
| 2007 Q2 | 557.45 Million USD | -2.51% |
| 2007 Q1 | 571.81 Million USD | -77.45% |
| 2007 FY | - USD | -45.65% |
| 2006 FY | - USD | 255.45% |
| 2006 Q2 | 377.9 Million USD | -1.3% |
| 2006 Q1 | 382.89 Million USD | 2.41% |
| 2006 Q3 | 780.36 Million USD | 106.5% |
| 2006 Q4 | 2.53 Billion USD | 224.91% |
| 2005 Q1 | 228.56 Million USD | -7.67% |
| 2005 FY | - USD | 78.38% |
| 2005 Q4 | 373.9 Million USD | 43.14% |
| 2005 Q3 | 261.21 Million USD | -7.76% |
| 2005 Q2 | 283.19 Million USD | 23.9% |
| 2004 Q1 | 129.69 Million USD | 4.89% |
| 2004 Q3 | 154.42 Million USD | -5.96% |
| 2004 Q4 | 247.55 Million USD | 60.31% |
| 2004 Q2 | 164.2 Million USD | 26.61% |
| 2004 FY | - USD | -24.32% |
| 2003 Q1 | 59.6 Million USD | 1392.59% |
| 2003 Q4 | 94.13 Million USD | 55.63% |
| 2003 Q2 | 107.77 Million USD | -79.44% |
| 2003 Q3 | 79.17 Million USD | -29.52% |
| 2003 FY | - USD | 662.09% |
| 2002 Q4 | 36.72 Million USD | -34.08% |
| 2002 FY | - USD | 140.91% |
| 2002 Q2 | 19.19 Million USD | 731.16% |
| 2002 Q3 | 35.91 Million USD | 146.22% |
| 2002 Q1 | -3.58 Million USD | 98.02% |
| 2001 Q1 | -22.35 Million USD | -53.01% |
| 2001 Q3 | -36.06 Million USD | -1106.22% |
| 2001 Q2 | -30.28 Million USD | -37.87% |
| 2001 FY | - USD | -627.66% |
| 2001 Q4 | -21.07 Million USD | 50.46% |
| 2000 Q1 | -1.55 Million USD | 42.09% |
| 2000 FY | - USD | -144.78% |
| 2000 Q2 | -2.55 Million USD | 36.58% |
| 2000 Q3 | -18.23 Million USD | -806.96% |
| 2000 Q4 | -15.33 Million USD | 20.17% |
| 1999 Q2 | -9.3 Million USD | 13.51% |
| 1999 Q3 | -23.4 Million USD | 141.15% |
| 1999 Q4 | -6.7 Million USD | -168.35% |
| 1999 FY | - USD | 82.98% |
| 1999 Q1 | -13.56 Million USD | 7.11% |
| 1998 Q3 | -13 Million USD | -4.15% |
| 1998 Q1 | -11.5 Million USD | 25.34% |
| 1998 Q2 | -19.1 Million USD | -46.06% |
| 1998 Q4 | -19.6 Million USD | 4.78% |
| 1998 FY | - USD | -46.9% |
| 1997 Q4 | -16.7 Million USD | -16.32% |
| 1997 Q2 | -700 Thousand USD | 67.55% |
| 1997 Q1 | -11.1 Million USD | 7.36% |
| 1997 FY | - USD | -31.33% |
| 1997 Q3 | -14.3 Million USD | -287.76% |
| 1996 Q3 | 6.3 Million USD | 113.48% |
| 1996 FY | - USD | -37.06% |
| 1996 Q4 | -11.5 Million USD | -779.17% |
| 1996 Q2 | -14.1 Million USD | -20.27% |
| 1996 Q1 | -12.2 Million USD | 0.0% |
| 1995 Q2 | -7.9 Million USD | 18.35% |
| 1995 Q3 | -8.8 Million USD | -15.73% |
| 1995 FY | - USD | -10.03% |
| 1995 Q1 | -8.9 Million USD | -47.3% |
| 1994 Q3 | -7 Million USD | 3.66% |
| 1994 Q4 | -7.4 Million USD | 6.33% |
| 1994 FY | - USD | 0.0% |
| 1994 Q1 | -8.3 Million USD | -25.0% |
| 1994 Q2 | -7.2 Million USD | 13.68% |
| 1993 Q4 | -6.7 Million USD | -7.04% |
| 1993 Q1 | -6.5 Million USD | -58.0% |
| 1993 Q2 | -5.3 Million USD | 18.99% |
| 1993 Q3 | -6.1 Million USD | -10.94% |
| 1992 FY | - USD | -188.89% |
| 1992 Q4 | -4.1 Million USD | -16.28% |
| 1992 Q3 | -3.3 Million USD | -26.47% |
| 1992 Q2 | -2.4 Million USD | 52.78% |
| 1992 Q1 | -7.2 Million USD | -1540.0% |
| 1991 Q1 | -4.9 Million USD | -5000.0% |
| 1991 Q2 | 200 Thousand USD | 104.08% |
| 1991 Q3 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 500 Thousand USD | 150.0% |
| 1991 FY | - USD | -50.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Amgen Inc. | 12.23 Billion USD | 14.213% |
| AstraZeneca PLC | 12.97 Billion USD | 19.118% |
| Biogen Inc. | 2.37 Billion USD | -341.565% |
| MIRA Pharmaceuticals, Inc. | - USD | -Infinity% |
| Scilex Holding Company | -109.1 Million USD | 9720.179% |
| Scilex Holding Company | -109.1 Million USD | 9720.179% |